RhumbLine Advisers’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

RhumbLine Advisers’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,076	Closed	-$227K	–	2967
2018 Q1	$227K	Buy	+6,076	New	+$255K	﹤0.01%	2555

RhumbLine Advisers's ARMO Position: Q2 2018 in Review

RhumbLine Advisers sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 6,076 shares — an estimated $227K sold.

RhumbLine Advisers first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $227K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

RhumbLine Advisers reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
RhumbLine Advisers sold 6,076 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $227K.
RhumbLine Advisers first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
RhumbLine Advisers's ARMO BioSciences, Inc. Common Stock position peaked at $227K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.